Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
about
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)Role of beta 2-glycoprotein I and anti-phospholipid antibodies in activation of protein C in vitroInteractions and molecular structure of cardiolipin and beta 2-glycoprotein 1 (beta 2-GP1)HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosusT cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individualsA phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infectionPulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodiesAnticardiolipin and anti-beta2glycoprotein-I antibodies in patients with systemic lupus erythematosus: comparison between Colombians and Spaniards.Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures.Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.Systemic lupus erythematosus in men: clinical and immunological characteristics.Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationships with clinical manifestations and disease activity in an Italian series.Reassessing the status of antiphospholipid syndrome in systemic lupus erythematosus.The impact of gender on clinical manifestations of primary antiphospholipid syndrome.Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndromeThe 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients.Attempts to make sense of the antiphospholipid syndrome.Antiphospholipid antibodies: paradigm in transition.Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosusComplement activation by anticardiolipin antibodiesIsotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.Antiphospholipid antibodies and recurrent pregnancy loss.Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.Activation of cultured vascular endothelial cells by antiphospholipid antibodies.'Primary', 'secondary' and other variants of the antiphospholipid syndrome.Seronegative antiphospholipid syndrome associated with plasminogen activator inhibitor.Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients.Demonstration of antiphospholipid antibody heterogeneity by phospholipid column chromatography and salt gradient elution techniques.Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome.Origin and pathogenesis of antiphospholipid antibodies.Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies.Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndromeSystemic lupus erythematosus in the elderly: clinical and immunological characteristics.Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome.Mixed connective tissue disease associated with autoimmune hepatitis and thyroiditis.
P2860
Q24558202-91F35F24-795E-4E4C-A198-7FF23184C73DQ24563574-5C185AA4-11EF-48F3-B6B3-C8AE4536829AQ24672569-0AF020C8-6122-42DF-AE17-699B224FCC2EQ28138464-8593D0E8-1C42-4688-957E-AC839890770BQ28143036-745775FF-5678-4FCF-9FA8-78CC6AB461AFQ28207774-89EAC26E-533E-440F-9CBD-2EE88D1B0FB4Q28340697-1A5C7892-F569-4D3B-B6D3-C3C734CBF2D2Q33328447-12607107-561F-4B19-A88F-D7FEE63873AEQ33329907-5F0B87D3-48CB-486E-9A29-4A8F8D573ECFQ33331408-DE9F5E76-0CE8-4AE0-881F-645528D86251Q33336296-8C6EF506-943D-4506-A6E4-80213711FF09Q33340713-DA7CBE23-FC3D-4ED6-9E3F-D2C8ADB2622AQ33355187-98880BED-A79A-4D63-ADA1-4D4B7F8A77AFQ33358817-124619E8-C268-46E0-B2B7-53113DFD3492Q33363443-43524FAB-C2F1-4722-9791-54D6DDCA545EQ33368554-53665913-B926-4EEB-9B88-E7A0DECC9828Q33369430-379F4367-94E8-4443-8BC9-4D768612FCF0Q33371184-CC01C645-1C0C-4412-8B77-6675E284B689Q33372890-53165A46-484A-46CF-AAE0-98D0106043F5Q33382848-9D214711-3851-455D-AA5C-13EC794F04F5Q33388232-60FF1C73-3C04-40BE-87F1-CCF913E45642Q33388763-38D195EA-2BCF-4901-BB5E-8C8FA38C7AE1Q33392824-0869FC95-15A5-4124-A4ED-46C4B80FFB99Q33416855-7A89A964-5BB9-4877-891B-9811CFB818DFQ33448386-4B81DC20-59D2-4391-A9D7-EBD9BF4F5658Q33488617-4E81CF98-3FB2-4ADA-9A22-A80859DF210AQ33490042-0732328A-4FEB-43AA-BF39-9D468B8A046FQ33491105-831DF8C8-C973-473B-88B8-D20BBAD0B729Q33491307-88FEB582-0030-4E9D-8D8F-7820C7D3F01BQ33495018-E29E4C7E-2443-4B08-9DC9-36C9C4D6ADBCQ33496557-1501CEDB-2E36-4BC3-974D-A58C2F26E638Q33497584-D0F1B77E-B813-4DA5-8DBC-DAF3D8A63E34Q33503275-90AD8869-41BE-4990-A200-00CA6C45FA11Q33504706-C0516CE5-04E6-4C8C-BD72-10AA86E59531Q33557638-21FA8D37-2845-4E1C-A154-82E6242417B7Q33561648-96511FC7-95D5-4129-AE6A-C6F725153A69Q33562467-9A142BCC-A74B-4D4B-BA5C-653084A10D1AQ33563933-4DD996FF-70A4-47E7-805B-7F627DB6618BQ33564539-9BAFDEC5-81F4-462A-8E40-234FA8A7DCD5Q33564591-EA8E045F-0C8B-443A-A741-CBFC3A5C6F06
P2860
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
@ast
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
@en
type
label
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
@ast
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
@en
prefLabel
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
@ast
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
@en
P2860
P50
P356
P1476
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
@en
P2860
P356
10.1136/ARD.46.1.1
P407
P577
1987-01-01T00:00:00Z